Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1984 2
1985 3
1986 5
1987 3
1988 8
1989 2
1990 4
1991 4
1992 2
1993 2
1994 2
1996 4
1999 1
2000 1
2001 1
2005 3
2006 2
2007 2
2008 1
2009 2
2012 1
2014 1
2016 1
2017 4
2018 4
2019 3
2021 2
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

70 results
Results by year
Filters applied: . Clear all
Page 1
Butoconazole.
[No authors listed] [No authors listed] 2018 Oct 31. Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006–. 2018 Oct 31. Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006–. PMID: 30000484 Free Books & Documents. Review.
Vaginal butoconazole has not been studied during breastfeeding. About 5.5% of a vaginal dose is absorbed and its plasma half-life is 21 to 24 hours. Because there is no published experience with butoconazole during breastfeeding, other agents may be preferred, espec …
Vaginal butoconazole has not been studied during breastfeeding. About 5.5% of a vaginal dose is absorbed and its plasma half-life is …
Candidiasis.
Powderly WG. Powderly WG. J Int Assoc Physicians AIDS Care. 1996 Oct;2(10):36-9. J Int Assoc Physicians AIDS Care. 1996. PMID: 11363911
Antifungal agents for oral or esophageal candidiasis may include nystatin, clotrimazole, ketoconazole, fluconazole, itraconazole, or amphotericin B; vulvovaginal disease is treated with clotrimazole, miconazole, or butoconazole in cream or suppository form. Since relapses …
Antifungal agents for oral or esophageal candidiasis may include nystatin, clotrimazole, ketoconazole, fluconazole, itraconazole, or amphote …
Comparison of three-day butoconazole treatment with seven-day miconazole treatment for vulvovaginal candidiasis.
Kaufman RH, Henzl MR, Brown D Jr, Horner DS, Krauss RH, Mehlisch DR, Moore DE, Prentice RL. Kaufman RH, et al. J Reprod Med. 1989 Jul;34(7):479-83. J Reprod Med. 1989. PMID: 2671362 Clinical Trial.
Eight to ten days after treatment completion, 88% of the butoconazole-treated patients and 91% of the miconazole-treated patients were Candida negative; 80% of the butoconazole-treated patients and 82% of the miconazole-treated patients were considered clinically cu …
Eight to ten days after treatment completion, 88% of the butoconazole-treated patients and 91% of the miconazole-treated patients wer …
Three-day treatment of vulvovaginal candidiasis.
Adamson GD. Adamson GD. Am J Obstet Gynecol. 1988 Apr;158(4):1002-5. doi: 10.1016/0002-9378(88)90114-7. Am J Obstet Gynecol. 1988. PMID: 3364485
Butoconazole nitrate, a newer imidazole, is effective for the treatment of vulvovaginal candidiasis when administered as a vaginal cream. ...The suppository form of butoconazole may offer a valuable therapeutic alternative for patients who wish to use it instead of
Butoconazole nitrate, a newer imidazole, is effective for the treatment of vulvovaginal candidiasis when administered as a vaginal cr
An evaluation of butoconazole nitrate 2% site release vaginal cream (Gynazole-1) compared to fluconazole 150 mg tablets (Diflucan) in the time to relief of symptoms in patients with vulvovaginal candidiasis.
Seidman LS, Skokos CK. Seidman LS, et al. Infect Dis Obstet Gynecol. 2005 Dec;13(4):197-206. doi: 10.1080/10647440500240615. Infect Dis Obstet Gynecol. 2005. PMID: 16338779 Free PMC article. Clinical Trial.

RESULTS: The median time to first relief of symptoms occurred at 17.5 h for butoconazole patients as compared to 22.9 h for fluconazole patients (p < 0.001). The time at which 75% of patients experienced first relief of symptoms was 24.5 h versus 46.3 h for butoconaz

RESULTS: The median time to first relief of symptoms occurred at 17.5 h for butoconazole patients as compared to 22.9 h for fluconazo …
Development and application of degradation kinetics of thin layer chromatographic densitometry and conductometric methods for butoconazole nitrate determination.
Sayed RA, Elmasry MS, Hassan WS, El-Mammli MY, Shalaby A. Sayed RA, et al. Ann Pharm Fr. 2018 Nov;76(6):453-463. doi: 10.1016/j.pharma.2018.07.007. Epub 2018 Aug 29. Ann Pharm Fr. 2018. PMID: 30172352
Two simple methods were developed for determination of butoconazole nitrate (BN). The first developed method was stability-indicating HPTLC-densitometric method (method A) which is based on the quantitative densitometric separation of butoconazole nitrate (BN) from …
Two simple methods were developed for determination of butoconazole nitrate (BN). The first developed method was stability-indicating …
Butoconazole nitrate 2% for vulvovaginal candidiasis. New, single-dose vaginal cream formulation vs. seven-day treatment with miconazole nitrate. Gynazole 1 Study Group.
Brown D, Henzl MR, Kaufman RH. Brown D, et al. J Reprod Med. 1999 Nov;44(11):933-8. J Reprod Med. 1999. PMID: 10589403 Clinical Trial.
OBJECTIVE: To compare the safety and efficacy of a single vaginal dose of a butoconazole nitrate 2% bioadhesive, sustained-release cream* (butoconazole 1-BSR) with a seven-day schedule of miconazole nitrate vaginal cream 2% (miconazole 7). ...A total of 205 patients …
OBJECTIVE: To compare the safety and efficacy of a single vaginal dose of a butoconazole nitrate 2% bioadhesive, sustained-release cr …
Treatment of recurrent vulvo-vaginal candidiasis with sustained-released butoconazole pessary.
Heng LZ, Chen Y, Tan TC. Heng LZ, et al. Singapore Med J. 2012 Dec;53(12):e269-71. Singapore Med J. 2012. PMID: 23268172 Free article.
This could be due to patient factors, drug application (such as leakage) or dosing factors. A sustained-release (SR) bioadhesive vaginal cream (2% butoconazole nitrate) has incorporated VagiSite technology, a topical drug delivery system that allows SR of the drug. We desc …
This could be due to patient factors, drug application (such as leakage) or dosing factors. A sustained-release (SR) bioadhesive vaginal cre …
Butoconazole nitrate.
Tatum DM, Eggleston M. Tatum DM, et al. Infect Control Hosp Epidemiol. 1988 Mar;9(3):122-4. doi: 10.1086/645809. Infect Control Hosp Epidemiol. 1988. PMID: 3280665 Clinical Trial. No abstract available.
70 results